Double-blind study of effects of enkephalinase inhibitor on adverse reactions to myelography.
The side effects in myelography are well known and frequently observed. The most common are headache, nausea, and vomiting. In this study, a rather new compound, Thiorphan, was examined, which displays an antinociceptive activity by inhibiting enkephalinase activity. Forty-two patients received intravenous infusions of Thiorphan before myelography. Another 42 patients were in a control group, and Thiorphan was not administered. In the treated group, postmyelographic headache was found in 24% (versus 52% in the control group). Nausea and vomiting were never seen. Low back pain or sciatica was diminished in 33% of cases. Enkephalin levels in cerebrospinal fluid were measured by a radioreceptor-assay method in both groups without any correlation.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000603:Amino Acids, Sulfur / Q000627:therapeutic use*; D001416:Back Pain / Q000517:prevention & control; D004311:Double-Blind Method; D005260:Female; D006261:Headache / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D009192:Myelography / Q000009:adverse effects*; D009325:Nausea / Q000517:prevention & control; D011480:Protease Inhibitors / Q000627:therapeutic use*; D012585:Sciatica / Q000517:prevention & control; D015244:Thiorphan; D008625:Tiopronin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D014839:Vomiting / Q000517:prevention & control
D000603:Amino Acids, Sulfur; D011480:Protease Inhibitors; D015244:Thiorphan; D008625:Tiopronin